Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia. Wondimu A, Postma MJ, van Hulst M. Vaccine 2022 Mar 2. pii: S0264-410X(22)00245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wondimu A, Postma MJ, van Hulst M. Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia. Vaccine 2022 Mar 2. pii: S0264-410X(22)00245.
PMID: 35248423